atherosclerotic cardiovascular disease
cardiac imaging
cardiovascular disease
chest pain
electrophysiology
heart failure
interventional cardiology
prevention
shared decision-making
structural heart
valvular heart disease
Journal
JACC. Advances
ISSN: 2772-963X
Titre abrégé: JACC Adv
Pays: United States
ID NLM: 9918419284106676
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
received:
07
09
2023
revised:
25
01
2024
accepted:
28
02
2024
medline:
12
8
2024
pubmed:
12
8
2024
entrez:
12
8
2024
Statut:
epublish
Résumé
Shared decision-making (SDM) and multidisciplinary team-based care delivery are recommended across several cardiology clinical practice guidelines. However, evidence for benefit and guidance on implementation are limited. Informed consent, the use of patient decision aids, or the documentation of these elements for governmental or societal agencies may be conflated as SDM. SDM is a bidirectional exchange between experts: patients are the experts on their goals, values, and preferences, and clinicians provide their expertise on clinical factors. In this Expert Panel perspective, we review the current state of SDM in team-based cardiovascular care and propose best practice recommendations for multidisciplinary team implementation of SDM.
Identifiants
pubmed: 39130036
doi: 10.1016/j.jacadv.2024.100981
pii: S2772-963X(24)00169-8
pmc: PMC11312306
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100981Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
Dr Perpetua has been a consultant for Edwards Lifesciences and is a consultant for Abbott Vascular. Ms. Palmer is a consultant for Edwards Lifesciences. Dr Beckman is a consultant for Norvartis, Janssen, and JanOne. Dr Keegan is a consultant for Edwards Lifesciences and Abbott Vascular. Dr Guibone is a consultant for Medtronic and Abbott Vascular. Dr Lauck is a consultant for Edwards Lifesciences. Dr Le has received research grant funding from Janssen and is a consultant for 10.13039/100008272Novartis. Dr Lindman is supported by R01AG073633 from the 10.13039/100000002National Institutes of Health and has been a consultant for and received investigator-initiated research grants from 10.13039/100006520Edwards Lifesciences. Dr Wyman has been a consultant for Edwards Lifesciences and Boston Scientific. Dr Gulati has been a consultant for Esperion, Boehringer Ingelheim, and Medtronic. There was no funding support for this expert panel. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.